Role of mechanistically-based pharmacokinetic/pharmacodynamic models in drug development : a case study of a therapeutic protein.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2006 AND VI 45 AND IP 2
Results: 8
1
2
Fosamprenavir : clinical pharmacokinetics and drug interactions of the amprenavir prodrug.
- Published in:
- 2006
- By:
- Publication type:
- journal article
3
Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.
- Published in:
- 2006
- By:
- Publication type:
- journal article
4
Fosamprenavir: Clinical Pharmacokinetics and Drug Interactions of the Amprenavir Prodrug.
- Published in:
- Clinical Pharmacokinetics, 2006, v. 45, n. 2, p. 137, doi. 10.2165/00003088-200645020-00002
- By:
- Publication type:
- Article
5
Pharmacokinetic interaction between levofloxacin and ciclosporin or tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation.
- Published in:
- 2006
- By:
- Publication type:
- journal article
6
Pharmacokinetics of darbepoetin alfa after intravenous or subcutaneous administration in patients with non-myeloid malignancies undergoing chemotherapy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
7
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
- Published in:
- 2006
- By:
- Publication type:
- commentary
8
The Authors' Reply.
- Published in:
- Clinical Pharmacokinetics, 2006, v. 45, n. 2, p. 214, doi. 10.2165/00003088-200645020-00007
- By:
- Publication type:
- Article